Compugen Ltd
CGEN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$199.01M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $199.01 Million |
|---|---|
| Enterprise Value | $207.59 Million |
| Earnings per Share | $0.38 |
| Beta | 2.79 |
| Outstanding Shares | 94,768,232 |
Return
| Return on Equity | 43.63% |
|---|---|
| Return on Assets | 28.08% |
| Return on Invested Capital | 32.93% |
Valuation & Multiples
| P/E Ratio | 5.4 |
|---|---|
| PEG | -31.97 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 2.73 |
| Enterprise Value to EBIT | 6.01 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.19 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 9, 2026
EPS
-$0.06
Est. -$0.08Revenue
$3.82 M
Est. $1.28 MNext Earnings Call
Expected Date
March 1, 2027
EPS Estimate
-$0.06
Consensus analyst estimateRevenue Estimate
$4.15 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 144.22% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.41%▼ 13.55% |
|---|---|
| Total Invested | $3.17M▼ 89.53% |
| Investors Holding | 20▼ 67.00% |
About Compugen Ltd
75 employees
CEO: Anat Cohen-Dayag
Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable, predictive computational discovery platforms to identify novel drug targets and develop therapeutics in the field of cancer immu...